InvestorsHub Logo
Followers 35
Posts 6969
Boards Moderated 1
Alias Born 04/04/2020

Re: marjac post# 365833

Saturday, 01/08/2022 5:09:07 PM

Saturday, January 08, 2022 5:09:07 PM

Post# of 427978
Marjac, legal question. All lipid modifying agents are considered to be primarily used for the treatment of CVD. Every insurance formulary I look at has them all listed under that heading. Could Amarin make the argument that a label instructing the use of gv to reduce TG, is in fact a label instructing the use of gv to reduce the risk of CVD?
Thanks.
Sleven,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News